{"id":46240,"date":"2022-07-15T16:01:59","date_gmt":"2022-07-15T14:01:59","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\/"},"modified":"2022-07-15T16:01:59","modified_gmt":"2022-07-15T14:01:59","slug":"altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\/","title":{"rendered":"Altasciences Continues Manufacturing Expansion in Philadelphia With Client\u2011Dedicated Building Project"},"content":{"rendered":"
\n

\nFollowing Agreement With Alladapt Immunotherapeutics, Inc.<\/i>\n<\/p>\n

LAVAL, Quebec–(BUSINESS WIRE)–#Alladapt<\/a>—Altasciences<\/a>\u2019 formulation, manufacturing, and analytical services<\/a> facilities in Philadelphia, PA, are undergoing further expansion. Altasciences\u2014an integrated CRO\/CDMO offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies\u2014is building client\u2011dedicated facilities for Alladapt Immunotherapeutics, Inc. (\u201cAlladapt\u201d), a private, clinical-stage biopharmaceutical company developing prescription therapeutics to address IgE-mediated food allergy, with a scheduled completion time in 2023.\n<\/p>\n

<\/a><\/p>\n

\nHaving developed the formulation and manufacturing processes to meet all of Alladapt\u2019s Phase I and II clinical trial needs, Altasciences has been contracted to continue the process with the construction of a new 53,000-square-foot building that will meet Alladapt\u2019s Phase III and commercial requirements. Altasciences will manage all aspects of this project, including warehousing, release management, manufacturing, quality assurance, and finished product release. The new building will have additional client dedicated capacity that can be used for Phase I through to commercial manufacturing services.\n<\/p>\n

\n\u201cWe are pleased to continue supporting Alladapt in their important goal of developing a single therapeutic to address a wide range of mono- and multi-food allergies, and we look forward to fulfilling their Phase III and commercial requirements,<\/i>\u201d stated Ben Reed, General Manager, CDMO Services at Altasciences.\n<\/p>\n

\n\u201cThe training Altasciences provides their CDMO workforce is second to none, as each team member is well-equipped to optimize and complete our manufacturing projects. We are proud to partner with Altasciences to continue advancing the clinical development of our potentially best in-class oral immunotherapy candidate, ADP101,<\/i>\u201d said Ashley Dombkowski, Ph.D., Chief Executive Officer and co-founder at Alladapt.\n<\/p>\n

\nAbout Altasciences<\/b>\n<\/p>\n

\nAltasciences<\/a> is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical<\/a> and clinical pharmacology<\/a> studies, including formulation, manufacturing, and analytical services<\/a>. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences\u2019 integrated, full-service solutions include preclinical safety testing<\/a>, clinical pharmacology and proof of concept<\/a>, bioanalysis<\/a>, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nJulie-Ann Cabana
\n
Altasciences<\/strong>
+1 514 601-9763
\n
jcabana@altasciences.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Following Agreement With Alladapt Immunotherapeutics, Inc. LAVAL, Quebec–(BUSINESS WIRE)–#Alladapt—Altasciences\u2019 formulation, manufacturing, and analytical services facilities in Philadelphia, PA, are undergoing further expansion. Altasciences\u2014an integrated CRO\/CDMO offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies\u2014is building client\u2011dedicated facilities for Alladapt Immunotherapeutics, Inc. (\u201cAlladapt\u201d), a private, clinical-stage biopharmaceutical company developing prescription … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46240","6":"format-standard","7":"category-industry"},"yoast_head":"\nAltasciences Continues Manufacturing Expansion in Philadelphia With Client\u2011Dedicated Building Project - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client\u2011dedicated-building-project\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Altasciences Continues Manufacturing Expansion in Philadelphia With Client\u2011Dedicated Building Project - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Following Agreement With Alladapt Immunotherapeutics, Inc. LAVAL, Quebec–(BUSINESS WIRE)–#Alladapt—Altasciences\u2019 formulation, manufacturing, and analytical services facilities in Philadelphia, PA, are undergoing further expansion. Altasciences\u2014an integrated CRO\/CDMO offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies\u2014is building client\u2011dedicated facilities for Alladapt Immunotherapeutics, Inc. (\u201cAlladapt\u201d), a private, clinical-stage biopharmaceutical company developing prescription ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client\u2011dedicated-building-project\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-15T14:01:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220715005047\/en\/761346\/21\/Altasciences_Gradient_V_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Altasciences Continues Manufacturing Expansion in Philadelphia With Client\u2011Dedicated Building Project\",\"datePublished\":\"2022-07-15T14:01:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\\\/\"},\"wordCount\":380,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220715005047\\\/en\\\/761346\\\/21\\\/Altasciences_Gradient_V_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\\\/\",\"name\":\"Altasciences Continues Manufacturing Expansion in Philadelphia With Client\u2011Dedicated Building Project - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220715005047\\\/en\\\/761346\\\/21\\\/Altasciences_Gradient_V_RGB.jpg\",\"datePublished\":\"2022-07-15T14:01:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220715005047\\\/en\\\/761346\\\/21\\\/Altasciences_Gradient_V_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220715005047\\\/en\\\/761346\\\/21\\\/Altasciences_Gradient_V_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Altasciences Continues Manufacturing Expansion in Philadelphia With Client\u2011Dedicated Building Project\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Altasciences Continues Manufacturing Expansion in Philadelphia With Client\u2011Dedicated Building Project - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client\u2011dedicated-building-project\/","og_locale":"en_US","og_type":"article","og_title":"Altasciences Continues Manufacturing Expansion in Philadelphia With Client\u2011Dedicated Building Project - Pharma Trend","og_description":"Following Agreement With Alladapt Immunotherapeutics, Inc. LAVAL, Quebec–(BUSINESS WIRE)–#Alladapt—Altasciences\u2019 formulation, manufacturing, and analytical services facilities in Philadelphia, PA, are undergoing further expansion. Altasciences\u2014an integrated CRO\/CDMO offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies\u2014is building client\u2011dedicated facilities for Alladapt Immunotherapeutics, Inc. (\u201cAlladapt\u201d), a private, clinical-stage biopharmaceutical company developing prescription ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client\u2011dedicated-building-project\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-15T14:01:59+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220715005047\/en\/761346\/21\/Altasciences_Gradient_V_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Altasciences Continues Manufacturing Expansion in Philadelphia With Client\u2011Dedicated Building Project","datePublished":"2022-07-15T14:01:59+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\/"},"wordCount":380,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220715005047\/en\/761346\/21\/Altasciences_Gradient_V_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\/","url":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\/","name":"Altasciences Continues Manufacturing Expansion in Philadelphia With Client\u2011Dedicated Building Project - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220715005047\/en\/761346\/21\/Altasciences_Gradient_V_RGB.jpg","datePublished":"2022-07-15T14:01:59+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220715005047\/en\/761346\/21\/Altasciences_Gradient_V_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220715005047\/en\/761346\/21\/Altasciences_Gradient_V_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/altasciences-continues-manufacturing-expansion-in-philadelphia-with-client%e2%80%91dedicated-building-project\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Altasciences Continues Manufacturing Expansion in Philadelphia With Client\u2011Dedicated Building Project"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46240"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46240\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}